Induction chemotherapy (IC) docetaxel (T), cisplatin (P), 5-fluorouracil (F) (TPF), or TP followed by concomitant boost radiotherapy (R) with or without cetuximab (E) for functional organ preservation (FOP) of resectable laryngeal and hypopharyngeal cancer (LHSCC): First results of the phase II randomized DeLOS-II study

Dietz, Andreas and Flentje, Michael and Hagen, Rudolf and Bockmuehl, Ulrike and Koelbl, Oliver and Schilling, Volker and Maschmeyer, Georg and Schroeder, Ursula and Sittel, Christian and Goerner, Martin and Lenarz, Thomas and Klussmann, Jens Peter and Guntinas-Lichius, Orlando and Rudack, Claudia and Reinisch, Sabine and Foerg, Thomas and Westhofen, Martin and Welkoborsky, Hans Juergen and Esser, Dirk and Keilholz, Ulrich (2014) Induction chemotherapy (IC) docetaxel (T), cisplatin (P), 5-fluorouracil (F) (TPF), or TP followed by concomitant boost radiotherapy (R) with or without cetuximab (E) for functional organ preservation (FOP) of resectable laryngeal and hypopharyngeal cancer (LHSCC): First results of the phase II randomized DeLOS-II study. JOURNAL OF CLINICAL ONCOLOGY, 32 (15supp): 6016. ISSN 0732-183X, 1527-7755

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Strahlentherapie
Depositing User: Petra Gürster
Date Deposited: 24 Jul 2020 09:23
Last Modified: 24 Jul 2020 09:23
URI: https://pred.uni-regensburg.de/id/eprint/10167

Actions (login required)

View Item View Item